Comparison of two equivalent model for end‐stage liver disease scores for hepatocellular carcinoma patients using data from the United Network for Organ Sharing liver transplant waiting list registry

@article{Alver2017ComparisonOT,
  title={Comparison of two equivalent model for end‐stage liver disease scores for hepatocellular carcinoma patients using data from the United Network for Organ Sharing liver transplant waiting list registry},
  author={Sarah K Alver and Douglas J. Lorenz and Kenneth Washburn and Michael R. Marvin and Guy N. Brock},
  journal={Transplant International},
  year={2017},
  volume={30},
  pages={1098–1109}
}
  • Sarah K Alver, Douglas J. Lorenz, +2 authors Guy N. Brock
  • Published in
    Transplant international…
    2017
  • Medicine
  • Transplant International
  • Patients with hepatocellular carcinoma (HCC) have been advantaged on the liver transplant waiting list within the United States, and a 6-month delay and exception point cap have recently been implemented to address this disparity. An alternative approach to prioritization is an HCC-specific scoring model such as the MELD Equivalent (MELDEQ ) and the mixed new deMELD. Using data on adult patients added to the UNOS waitlist between 30 September 2009 and 30 June 2014, we compared projected dropout… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    Citations

    Publications citing this paper.
    SHOWING 1-3 OF 3 CITATIONS

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 27 REFERENCES

    MELDEQ : An alternative Model for End-Stage Liver Disease score for patients with hepatocellular carcinoma.

    VIEW 4 EXCERPTS

    FY.Minimal transplant survival benefit for hepatocellular carcinoma: is it real or an overestimation of waitlist life expectancy? Gastroenterology2016;150:533

    • MehtaN, J Heimbach, R Hirose, JP Roberts, Yao
    • 2016
    VIEW 1 EXCERPT

    How can we improve prioritization for liver transplantation in patients with hepatocellular carcinoma?

    • George N. Ioannou
    • Medicine
    • Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
    • 2016
    VIEW 2 EXCERPTS

    Projected outcomes of 6-month delay in exception points versus an equivalent Model for End-Stage Liver Disease score for hepatocellular carcinoma liver transplant candidates.

    in patients with hepatocellular carcinoma

    • RB Freeman, EB Edwards, AM Harper
    • liver transplantation
    • 2016

    Hepatocellular carcinoma in patients listed for liver transplantation: Current and future allocation policy and management strategies for the individual patient.

    • Joel P Wedd, Eric M. Nordstrom, +5 authors Scott W. Biggins
    • Medicine
    • Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
    • 2015

    How can we improve prioritization for

    • GN Ioannou
    • Organ Procurement and Transplantation Network ( OPTN ) Policies , Policy 9 . 3 . F : Candidates with Hepatocellular Carcinoma ( HCC ) effective 10 / 8 /
    • 2015